Cancer diagnosis, risk assessment and prediction of therapeutic response by means of DNA methylation markers

Heidi Fiegl, Karim Elmasry

Research output: Contribution to journalReview article

Abstract

Epigenetic alterations are heritable changes in gene expression without an accompanying change in primary DNA sequence. Two major mechanisms that cause epigenetic changes are post-translational histone modifications and DNA methylation at cytosine bases within a CpG dinucleotide. Epigenetic defects have turned out to be one of the most common molecular alterations in human neoplasia. Promoter hypermethylation is associated with loss of expression of tumour suppressor genes in cancer. The analysis of aberrant DNA methylation is gaining strength in the fields of cancer risk assessment, diagnosis, and therapy monitoring in different cancer types. These issues are discussed in this review.

Original languageEnglish (US)
Pages (from-to)89-96
Number of pages8
JournalDisease Markers
Volume23
Issue number1-2
DOIs
StatePublished - Jan 1 2007
Externally publishedYes

Fingerprint

DNA Methylation
Genetic Markers
Risk assessment
Epigenomics
DNA sequences
Cytosine
Gene expression
Histones
Tumors
Neoplasms
Histone Code
Genes
Defects
Monitoring
Therapeutics
Post Translational Protein Processing
Tumor Suppressor Genes
Gene Expression

Keywords

  • Cancer risk assessment
  • Diagnostics
  • Methylation
  • Prediction

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Cancer diagnosis, risk assessment and prediction of therapeutic response by means of DNA methylation markers. / Fiegl, Heidi; Elmasry, Karim.

In: Disease Markers, Vol. 23, No. 1-2, 01.01.2007, p. 89-96.

Research output: Contribution to journalReview article

@article{04f4557f44524da18a5af1affd39d93a,
title = "Cancer diagnosis, risk assessment and prediction of therapeutic response by means of DNA methylation markers",
abstract = "Epigenetic alterations are heritable changes in gene expression without an accompanying change in primary DNA sequence. Two major mechanisms that cause epigenetic changes are post-translational histone modifications and DNA methylation at cytosine bases within a CpG dinucleotide. Epigenetic defects have turned out to be one of the most common molecular alterations in human neoplasia. Promoter hypermethylation is associated with loss of expression of tumour suppressor genes in cancer. The analysis of aberrant DNA methylation is gaining strength in the fields of cancer risk assessment, diagnosis, and therapy monitoring in different cancer types. These issues are discussed in this review.",
keywords = "Cancer risk assessment, Diagnostics, Methylation, Prediction",
author = "Heidi Fiegl and Karim Elmasry",
year = "2007",
month = "1",
day = "1",
doi = "10.1155/2007/293138",
language = "English (US)",
volume = "23",
pages = "89--96",
journal = "Disease Markers",
issn = "0278-0240",
publisher = "IOS Press",
number = "1-2",

}

TY - JOUR

T1 - Cancer diagnosis, risk assessment and prediction of therapeutic response by means of DNA methylation markers

AU - Fiegl, Heidi

AU - Elmasry, Karim

PY - 2007/1/1

Y1 - 2007/1/1

N2 - Epigenetic alterations are heritable changes in gene expression without an accompanying change in primary DNA sequence. Two major mechanisms that cause epigenetic changes are post-translational histone modifications and DNA methylation at cytosine bases within a CpG dinucleotide. Epigenetic defects have turned out to be one of the most common molecular alterations in human neoplasia. Promoter hypermethylation is associated with loss of expression of tumour suppressor genes in cancer. The analysis of aberrant DNA methylation is gaining strength in the fields of cancer risk assessment, diagnosis, and therapy monitoring in different cancer types. These issues are discussed in this review.

AB - Epigenetic alterations are heritable changes in gene expression without an accompanying change in primary DNA sequence. Two major mechanisms that cause epigenetic changes are post-translational histone modifications and DNA methylation at cytosine bases within a CpG dinucleotide. Epigenetic defects have turned out to be one of the most common molecular alterations in human neoplasia. Promoter hypermethylation is associated with loss of expression of tumour suppressor genes in cancer. The analysis of aberrant DNA methylation is gaining strength in the fields of cancer risk assessment, diagnosis, and therapy monitoring in different cancer types. These issues are discussed in this review.

KW - Cancer risk assessment

KW - Diagnostics

KW - Methylation

KW - Prediction

UR - http://www.scopus.com/inward/record.url?scp=33847406279&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33847406279&partnerID=8YFLogxK

U2 - 10.1155/2007/293138

DO - 10.1155/2007/293138

M3 - Review article

C2 - 17325428

AN - SCOPUS:33847406279

VL - 23

SP - 89

EP - 96

JO - Disease Markers

JF - Disease Markers

SN - 0278-0240

IS - 1-2

ER -